Home Tags Genetics
The coronavirus mutates more slowly than the flu — which means a vaccine will likely be effective long-term
The mutation rate of the new coronavirus suggests a one-time vaccine would be sufficient to confer long-term immunity, according to experts.
Ancient humans interbred with a mysterious archaic population 700,000 years ago, a study found — it’s the earliest known mating between di...
A new analysis of ancient DNA revealed that different populations of our human ancestors interbred as early as 700,000 years ago.
The genetic code of the Wuhan coronavirus shows it’s 80% similar to SARS. New research suggests a potential way to neutralize the virus.
The Wuhan coronavirus that has infected more than 17,000 people is closely related to SARS. Experts say the virus probably jumped from bats to people.
DNA-testing giant 23andMe is laying off about 14% of its staff as sales of consumer genetics tests failed to take off the way companies expected.
A Harvard geneticist is creating a dating app that matches users based on DNA, and people are worried it’s eugenics
Harvard geneticist George Church said his dating app concept could prevent genetic disease, but critics say the concept is discriminatory.
Apple is reportedly rolling out a new perk for employees: free genetic testing at its on-site wellness clinics
Apple now runs its own health clinics known as "AC Wellness" that allow workers to get medical treatment close to their offices.
Dispensed: The state of the consumer genetics market, a thorny issue facing Medicare for All, and a very Happy Thanksgiving to you all
Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.
I’ve taken DNA tests from Ancestry and 23andMe. Here’s the one critical thing you need to know before you buy a kit.
I've taken 23andMe and Ancestry's genetic tests. I wish I'd fully realized how much my ancestry results might change before taking the tests.
Jeffrey Epstein had a ‘Frankenstein’-like plan to analyze human DNA in the US Virgin Islands, and it reportedly pulled in $200 million
Epstein pursued an outlandish scheme to launch a 'DNA mining' startup. Scientists said his plan made no sense.
Bank of America Merrill Lynch's "underperform" rating marks the first time since March a Wall Street firm has recommended selling.